The association between CD14 gene C-260T polymorphism and coronary heart disease risk: A meta-analysis

Molecular Biology Reports

Volumn 40, Issue 6, 2013, Pages 4001-4008

  Pu, Hong ^a   Yin, Jiong ^a   Wu, Yan ^a   Zhang, Dongming ^a   Wang, Yanian ^a   Zhou, Rong ^a   Jiang, Lijuan ^a   Liu, Yan ^a  

^a No 85 Hospital of PLA   (China)

Author keywords

CD14; Coronary heart disease; Meta analysis; Myocardial infarction; Polymorphism

Indexed keywords

CD14 ANTIGEN;

ALLELE; ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; CD14 GENE; EAST ASIAN; ETHNIC DIFFERENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; RISK FACTOR; SAMPLE SIZE;

ANTIGENS, CD14; CORONARY DISEASE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS;

EID: 84877758943     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2478-y     Document Type: Article

References (40)

1. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding protein. Science 249:1431-1433
2. Schumann RR, Rietschel ET, Loppnow H (1994) The role of CD14 and lipopolysaccharide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol 183:279-297
3. Kane JP, Havel RJ (1999) Polymorphism of the lipopolysaccharide receptor (CD14) and myocardial infarction: new evidence for a role of Gram-negative bacterial infection? Circulation 99:3210-3212
4. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM (1996) Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 64:1906-1912
5. Gupta D, Kirkland TN, Viriyakosol S, Dziarski R (1996) CD14 is a cell-activating receptor for bacterial peptidoglycan. J Biol Chem 271:23310-23316
6. Baldini M, Lohman IC, Halonen M et al (1999) A Polymorphism*in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20:976-983
7. Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283:2008-2012
8. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-129
9. Thompson SG, Sharp SJ (1999) Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18:2693-2708
10. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634
11. Unkelbach K, Gardemann A, Kostrzewa M, Philipp M, Tillmanns H, Haberbosch W (1999) A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile. Arterioscler Thromb Vasc Biol 19:932-938
12. Hubacek JA, Rothe G, Pit'ha J, Skodová Z, Stank V, Poledne R, Schmitz G (1999) C(-260)- >T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99:3218-3220
13. Shimada K, Watanabe Y, Mokuno H, Iwama Y, Daida H, Yamaguchi H (2000) Common polymorphism in the promoter of the CD14 monocyte receptor gene is associated with acute myocardial infarction in Japanese men. Am J Cardiol 86:682-684
14. Zee RY, Lindpaintner K, Struk B, Hennekens CH, Ridker PM (2001) A prospective evaluation o4f the CD14 C(-260)T gene polymorphism and the risk of myocardial infarction. Atherosclerosis 154:699-702
15. Nauck M, Winkelmann BR, Hoffmann MM, Bohm BO, Wieland H, Marz W (2002) C(-260)T polymorphism in the promoter of the CD14 gene is not associated with coronary artery disease and myocardial infarction in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. J Am Coll Cardiol 90:1249-1252
16. Koch W, Kastrati A, Mehilli J, von Beckerath N, Schomig A (2002) CD14 gene-159C/T polymorphism is not associated with coronary artery disease and myocardial infarction. Am Heart J 143:971-976
17. Koenig W, Khuseyinova N, Hoffmann MM et al (2002) CD14 C(-260)3T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease. J Am Coll Cardiol 40:34-42
18. Pan M, Gu WD, Chen F et al (2003) C(-260)T polymorphism in CD14 gene promoter and its association with coronary heart disease in Chinese population. Zhongguo Wu Zhen Xue Za Zhi 3:1458-1459 (In Chinese)
19. Hohda S, Kimura A, Sasaoka T et al (2003) Association study of CD14 polymorphism with myocardial infarction in a Japanese population. Jpn Heart J 44:613-622
20. Longobardo MT, Cefalu AB, Pezzino F et al (2003) The C(-260)3T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction. Clin Exp Med 3:161-165
21. Morange PE, Tiret L, Saut N et al (2004) TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: the PRIME Study. Eur J Hum Genet 12:1041-1049
22. Arroyo-Espliguero R, El-Sharnouby K, Vazquez-Rey E, Kalidas K, Jeffery S, Kaski JC (2005) CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes. Int J Cardiol 98:307-312
23. Morange PE, Saut N, Alessi MC et al (2005) Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study. Atherosclerosis 179:317-323
24. Li Y, Xiong XQ, Zhang PA, Ming KH (2005) Association of C-159T polymorphism in promoter region of CD14 and coronary heart disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22:687-690 (In Chinese)
25. Hu R, Cheng LX, He MA, Wu TC (2006) Polymorphism in the promoter of the CD14 monocyte receptor gene is a risk factor for coronary heart disease in Wuhan population. Zhongguo Lao Nian Xin Xue Guan Bing Za Zhi 8:184-186 (In Chinese)
26. Chen F (2006) Distributionof-159C/T gene polymorphism in promoter Region of CD14 and its significance for plasma lipids levels. Shi Yong Yu Fang Yi Xue 13:844-847 (In Chinese)
27. Wei YS, Liu YG, Tang RG, Lan JS (2006) Association between CD14 gene promoter region polymorphisms and coronary heart disease. Di Si Jun Yi Da Xue Xue Bao 27:630-633 (In Chinese)
28. Li L, Zhang K, Qiu F et al (2007) Association of C (-159)T polymorphism in the promoter of CD14 gene with coronary heart disease in Han population of Jiangsu province. Zhongguo Zu Zhi Gong Cheng Yan Jiu Yu Lin Chuang Kang Fu 11:8749-8752 (In Chinese)
29. Giacconi R, Caruso C, Lio D et al (2007) CD14 C (-260)T polymorphism, atherosclerosis, elderly: role of cytokines and metallothioneins. Int J Cardiol 120:45-51
30. Lorenzova A, Stanek V, Gebauerova M et al (2007) High-sensitivity C-reactive protein concentration in patients with myocardial infarction-environmental factors, and polymorphisms in interleukin-10 and CD14 genes. Clin Chem Lab Med 45:855-861
31. Cai NG, Cheng JJ, Luo Q et al (2007) Study of the relationship between CD14 gene promoter C(-260)T point mutation and plasma IL-6 and coronary artery disease in northern Chinese Han population. Zhongguo Lao Nian Xue Za Zhi 27:2300-2302 (In Chinese)
32. Xie YX, Bu-Ai JE, Ma YT, Ma X, Fu ZY, Jia ZH (2008) Distribution of -260C/T single nucleotide polymorphisms (SNP) in the promoter region of CD 14 gene and its significance for coronary heart disease and plasma lipids levels between the Han and the Uyghur people in Xinjiang. Zhongguo Xin Xue Guan Bing Yan Jiu 6:403-406 (In Chinese)
33. Haberbosch W, Unkelbach K, Schuster D, Gardemann A, Tillmanns H, Hölschermann H (2009) CD14 promoter polymorphism (- 159C- > t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk. Thorac Cardiovasc Surg 57:386-390
34. Banerjee I, Pandey U, Hasan OM, Parihar R, Tripathi V, Ganesh S (2009) Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis 27:88-94
35. Liu XQ, Yang JY (2010) The association between C-159T polymorphism in promoter region of CD l4 polymorphism and coronary heart disease. Yi Xue Xin Zhi Za Zhi 20:427-429 (In Chinese)
36. Rizzello V, Liuzzo G, Trabetti E et al (2010) Role of the CD14 C(S260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease. J Cardiovasc Med (Hagerstown) 11:20-25
37. Liu ZR, Liu GY, Wei YS, Pan XS, Huang ZH, Meng LQ (2010) Serum CD l4 levels and the genotypes of CD l4 gene in patients with acute myocardial infarction. Zhongguo Lao Nian Xue Za Zhi 30:743-745 (In Chinese)
38. Sediri Y, Hammami S, Kallel A et al (2011) C(-260)T polymorphism in the promoter of CD 14 gene is not associated with myocardial infarction in the Tunisian population. Exp Mol Pathol 90:276-279
39. LeVan TD, Bloom JW, Bailey TJ et al (2001) A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 167:5838-5844
40. Ziegler-Heitbrock HW, Ulevitch RJ (1993) CD14: cell surface receptor and differentiation marker. Immunol Today 14:121-125